Business | Press Trust of India | Tuesday April 12, 2016
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
www.ndtv.com/business